Home › Funds › Royce & Associates › APYX
Royce & Associates position in APYX
APYX MEDICAL CORPORATION · Health Care
Latest position (Q2 2026)3.27M sh
Reported value held$14.70M
Portfolio Weight0.12%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 543.80K | $7.53M | New |
| Q4 2021 | 474.07K | $6.08M | Reduce |
| Q1 2022 | 462.47K | $3.02M | Reduce |
| Q2 2022 | 469.27K | $2.75M | Add |
| Q3 2022 | 884.27K | $3.97M | Add |
| Q4 2022 | 798.47K | $1.87K | Reduce |
| Q1 2023 | 1.46M | $4.20K | Add |
| Q2 2023 | 1.60M | $8.06M | Add |
| Q3 2023 | 2.01M | $6.43M | Add |
| Q4 2023 | 2.16M | $5.66M | Add |
| Q1 2024 | 2.44M | $3.31M | Add |
| Q2 2024 | 2.50M | $3.35M | Add |
| Q3 2024 | 2.58M | $3.20M | Add |
| Q4 2024 | 2.62M | $4.13M | Add |
| Q1 2025 | 2.53M | $3.46M | Reduce |
| Q2 2025 | 2.44M | $5.49M | Reduce |
| Q3 2025 | 2.47M | $5.30M | Add |
| Q4 2025 | 2.44M | $8.55M | Reduce |
| Q1 2026 | 2.61M | $9.64M | Add |
| Q2 2026 | 3.27M | $14.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding APYX
- Vanguard Group 1.57M sh · $5.48M · Q4 2025
- BlackRock Inc 560.99K sh · $2.52M · Q2 2026
- Renaissance Technologies 554.28K sh · $2.49M · Q2 2026
- Geode Capital Management 400.60K sh · $1.80M · Q2 2026
- Millennium Management 242.66K sh · $1.09M · Q2 2026
- Marshall Wace 236.47K sh · $1.06M · Q2 2026
- Citadel Advisors 168.34K sh · $755.86K · Q2 2026
- Northern Trust Corp 78.57K sh · $352.77K · Q2 2026
- Goldman Sachs Group 44.39K sh · $199.30K · Q2 2026
- Morgan Stanley 41.34K sh · $185.60K · Q2 2026
- Point72 Asset Management 26.35K sh · $118.31K · Q2 2026